Home › Multiple Sclerosis › Missouri
Multiple Sclerosis clinical trials in Missouri
8 studies for Multiple Sclerosis are looking for participants at sites in Missouri.
Cities in Missouri
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- and 6 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- Washington University, St. Louis, St Louis
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT07477639A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Washington University School of Medicine, St Louis
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06782490An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, St Louis
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Aug 25, 2026 · NCT07224373Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.
- Washington University School of Medicine in St. Louis, St Louis
RecruitingObservational study
Ages 40 to 70 · All sexes · Updated Aug 11, 2026 · NCT07758270This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
- Washington University in St. Louis, St Louis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07115017A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Washington University School of Medicine Neurology Clinical Unit, St Louis
RecruitingPhase 2
Ages 18 to 55 · All sexes · Updated Jun 15, 2026 · NCT06735248Smoldering Inflammation in MS
- Barnes Jewish Center for Clinical Imaging Research, St Louis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT06591429From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.